These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38509413)

  • 1. Effect of Nasal Inhalation on Drug Particle Deposition and Size Distribution in the Upper Airway: With Soft Mist Inhalers.
    Sadeghi T; Fatehi P; Pakzad L
    Ann Biomed Eng; 2024 May; 52(5):1195-1212. PubMed ID: 38509413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.
    Ahookhosh K; Saidi M; Mohammadpourfard M; Aminfar H; Hamishehkar H; Farnoud A; Schmid O
    Eur J Pharm Sci; 2021 Sep; 164():105911. PubMed ID: 34129919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Soft Mist Inhaler Aerosol Velocity, Size, and Deposition Inside the Mouth-A Computational Fluid Dynamics Study.
    Sadeghi T; Pakzad L; Fatehi P
    J Biomech Eng; 2023 Jun; 145(6):. PubMed ID: 36826406
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wei X; Hindle M; Kaviratna A; Huynh BK; Delvadia RR; Sandell D; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):358-371. PubMed ID: 29878859
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity.
    Alatrash A; Mehri R; Ogrodnik N; Matida E; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):293-302. PubMed ID: 31259646
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device.
    Spence BM; Longest W; Wei X; Dhapare S; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):224-241. PubMed ID: 30855199
    [No Abstract]   [Full Text] [Related]  

  • 10. In Vitro Evaluation of Aerosol Performance and Delivery Efficiency During Mechanical Ventilation Between Soft Mist Inhaler and Pressurized Metered-Dose Inhaler.
    Ke WR; Wang WJ; Lin TH; Wu CL; Huang SH; Wu HD; Chen CC
    Respir Care; 2020 Jul; 65(7):1001-1010. PubMed ID: 32071134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P; Hederer B; Austen G; Dewberry H; Meyer T
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mehri R; Alatrash A; Ogrodnik N; Matida EA; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):242-250. PubMed ID: 33170059
    [No Abstract]   [Full Text] [Related]  

  • 15. CFD Guided Optimization of Nose-to-Lung Aerosol Delivery in Adults: Effects of Inhalation Waveforms and Synchronized Aerosol Delivery.
    Dutta R; Spence B; Wei X; Dhapare S; Hindle M; Longest PW
    Pharm Res; 2020 Sep; 37(10):199. PubMed ID: 32968848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Efficiency Nose-to-Lung Aerosol Delivery in an Infant: Development of a Validated Computational Fluid Dynamics Method.
    Bass K; Boc S; Hindle M; Dodson K; Longest W
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):132-148. PubMed ID: 30556777
    [No Abstract]   [Full Text] [Related]  

  • 18. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patients' real-world post-dispensing use and storage environments of tiotropium bromide Respimat® soft mist inhaler on its in vitro dose delivery and lung deposition.
    Ammari WG; Khalil Mohammad M; Tayyem RF
    Pulm Pharmacol Ther; 2019 Oct; 58():101829. PubMed ID: 31352077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
    Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
    Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.